The funding round was led by angel investor Ashley Cooper with participation from Angels Invest Wales and Hambro Perks Insurtech Gateway.
"David and his co-founders make an impressive team who have developed a massively scalable, market leading technology that addresses a real need in a huge growth sector. Our investment syndicate is excited to be backing DAS and I am delighted to have led this funding round accessing the Wales Angel Co-investment Fund."
The funding was led by Andrew Diplock as the first deal for the Wales Angel Co-investment Fund.
"This is a show of faith from investors that this is a business that’s worth investing in, and they think it’s an exciting opportunity in a sector that’s growing fast."
The funding was led by the Development Bank of Wales to support the commercial launch of the Podium device.
"Detecting diabetic foot complications as early as possible is crucial as people with diabetes could suffer from a loss of feeling in their feet, which can lead to foot ulcers which increases the risk of amputation. Once a patient has received an amputation, their quality of life is impacted. More worryingly, life expectancy is 5 years post-amputation, on average."